Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04479241 |
Title | A Phase 1 Study of PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Istari Oncology, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California San Francisco | San Francisco | California | 94143 | United States | Details | |
UConn Health | Farmington | Connecticut | 06030 | United States | Details | |
Baptist MD Anderson Cancer Center | Jacksonville | Florida | 32207 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | United States | Details | |
The Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
Oregon Health and Science University | Portland | Oregon | 97239 | United States | Details |